Fidelity Advisor Healthy Future Z holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Fidelity Advisor Healthy Future Fund - Class Z FAPNX
- NAV / 1-Day Return 14.41 / +0.90 %
- Total Assets 14.3M
-
Adj. Expense Ratio
0.900%
- Expense Ratio 0.900%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Large Growth
- Investment Style Large Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.83%
- Turnover 80%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 10:26 PM GMT+0
Morningstar’s Analysis FAPNX
Will FAPNX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 35.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Johnson & Johnson | 4.76 | 699,451 | Healthcare |
UnitedHealth Group Inc | 4.40 | 646,810 | Healthcare |
CVS Health Corp | 4.39 | 645,537 | Healthcare |
Procter & Gamble Co | 3.83 | 563,356 | Consumer Defensive |
Tesla Inc | 3.39 | 498,204 | Consumer Cyclical |
Welltower Inc | 3.11 | 457,597 | Real Estate |
Unilever PLC | 3.01 | 441,965 | Consumer Defensive |
Chubb Ltd | 2.77 | 407,336 | Financial Services |
Hitachi Ltd | 2.70 | 397,031 | Industrials |
Gilead Sciences Inc | 2.69 | 394,825 | Healthcare |